Smith Nancy Freda bought TPST
September 22, 2026 · Form 4 insider transaction
Smith Nancy Freda bought 25,000 shares of Tempest Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 10 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderSmith Nancy Freda
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateSeptember 22, 2026
Filing dateOctober 2, 2026
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to each such stock option will vest over a three-year period, with one-third of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.